These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 26031187)

  • 1. Subgroup Identification in Personalized Treatment of Alcohol Dependence.
    Hou J; Seneviratne C; Su X; Taylor J; Johnson B; Wang XQ; Zhang H; Kranzler HR; Kang J; Liu L
    Alcohol Clin Exp Res; 2015 Jul; 39(7):1253-9. PubMed ID: 26031187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenetic approach at the serotonin transporter gene as a method of reducing the severity of alcohol drinking.
    Johnson BA; Ait-Daoud N; Seneviratne C; Roache JD; Javors MA; Wang XQ; Liu L; Penberthy JK; DiClemente CC; Li MD
    Am J Psychiatry; 2011 Mar; 168(3):265-75. PubMed ID: 21247998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ondansetron reduces naturalistic drinking in nontreatment-seeking alcohol-dependent individuals with the LL 5'-HTTLPR genotype: a laboratory study.
    Kenna GA; Zywiak WH; Swift RM; McGeary JE; Clifford JS; Shoaff JR; Vuittonet C; Fricchione S; Brickley M; Beaucage K; Haass-Koffler CL; Leggio L
    Alcohol Clin Exp Res; 2014 Jun; 38(6):1567-74. PubMed ID: 24773166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A within-group design of nontreatment seeking 5-HTTLPR genotyped alcohol-dependent subjects receiving ondansetron and sertraline.
    Kenna GA; Zywiak WH; McGeary JE; Leggio L; McGeary C; Wang S; Grenga A; Swift RM
    Alcohol Clin Exp Res; 2009 Feb; 33(2):315-23. PubMed ID: 19032576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study suggests gene may predict success of therapies for alcohol dependence.
    Kuehn BM
    JAMA; 2011 Mar; 305(10):984-5. PubMed ID: 21386072
    [No Abstract]   [Full Text] [Related]  

  • 6. Personalized treatment of alcohol dependence.
    Kranzler HR; McKay JR
    Curr Psychiatry Rep; 2012 Oct; 14(5):486-93. PubMed ID: 22810115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, double-blind, placebo-controlled, pharmacogenetic study of ondansetron for treating alcohol use disorder.
    Seneviratne C; Gorelick DA; Lynch KG; Brown C; Romer D; Pond T; Kampman K; Kranzler HR
    Alcohol Clin Exp Res; 2022 Oct; 46(10):1900-1912. PubMed ID: 36055978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of genotype combinations that can predict the outcome of the treatment of alcohol dependence using the 5-HT(3) antagonist ondansetron.
    Johnson BA; Seneviratne C; Wang XQ; Ait-Daoud N; Li MD
    Am J Psychiatry; 2013 Sep; 170(9):1020-31. PubMed ID: 23897038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medications for alcohol dependence--new vistas.
    Kranzler HR
    JAMA; 2000 Aug 23-30; 284(8):1016-7. PubMed ID: 10944648
    [No Abstract]   [Full Text] [Related]  

  • 10. A prospective, open-label trial of ondansetron in adolescents with alcohol dependence.
    Dawes MA; Johnson BA; Ait-Daoud N; Ma JZ; Cornelius JR
    Addict Behav; 2005 Jul; 30(6):1077-85. PubMed ID: 15925118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combining ondansetron and naltrexone effectively treats biologically predisposed alcoholics: from hypotheses to preliminary clinical evidence.
    Johnson BA; Ait-Daoud N; Prihoda TJ
    Alcohol Clin Exp Res; 2000 May; 24(5):737-42. PubMed ID: 10832917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variable selection for random effects two-part models.
    Han D; Liu L; Su X; Johnson B; Sun L
    Stat Methods Med Res; 2019 Sep; 28(9):2697-2709. PubMed ID: 30001684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reductions in and relations between "craving" and drinking in a prospective, open-label trial of ondansetron in adolescents with alcohol dependence.
    Dawes MA; Johnson BA; Ma JZ; Ait-Daoud N; Thomas SE; Cornelius JR
    Addict Behav; 2005 Oct; 30(9):1630-7. PubMed ID: 16084024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combining ondansetron and naltrexone treats biological alcoholics: corroboration of self-reported drinking by serum carbohydrate deficient transferrin, a biomarker.
    Ait-Daoud N; Johnson BA; Javors M; Roache JD; Zanca NA
    Alcohol Clin Exp Res; 2001 Jun; 25(6):847-9. PubMed ID: 11410720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Precision medicine: Subgroup identification in longitudinal trajectories.
    Wei Y; Liu L; Su X; Zhao L; Jiang H
    Stat Methods Med Res; 2020 Sep; 29(9):2603-2616. PubMed ID: 32070237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ondansetron reduces the craving of biologically predisposed alcoholics.
    Johnson BA; Roache JD; Ait-Daoud N; Zanca NA; Velazquez M
    Psychopharmacology (Berl); 2002 Apr; 160(4):408-13. PubMed ID: 11919668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pilot study of full-dose ondansetron to treat heavy-drinking men withdrawing from alcohol in Brazil.
    Corrêa Filho JM; Baltieri DA
    Addict Behav; 2013 Apr; 38(4):2044-51. PubMed ID: 23396176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An analysis of moderators in the COMBINE study: Identifying subgroups of patients who benefit from acamprosate.
    Gueorguieva R; Wu R; Tsai WM; O'Connor PG; Fucito L; Zhang H; O'Malley SS
    Eur Neuropsychopharmacol; 2015 Oct; 25(10):1586-99. PubMed ID: 26141511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Misuse of alcohol and new drug treatments].
    Paille F
    Rev Prat; 2011 Dec; 61(10):1386-91. PubMed ID: 22288352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ondansetron alters human alcohol intoxication.
    Swift RM; Davidson D; Whelihan W; Kuznetsov O
    Biol Psychiatry; 1996 Sep; 40(6):514-21. PubMed ID: 8879472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.